APA (7th ed.) Citation

K, Y., Y, L., K, S., M, P., T, L., M, W., . . . T, C. (2025). ADAM22 enhances lymphatic metastasis and epithelial-mesenchymal transition in head and neck squamous cell carcinoma cells through integrin signaling. Medical oncology (Northwood, London, England), 42(7), 236. https://doi.org/10.1007/s12032-025-02789-z

Chicago Style (17th ed.) Citation

K, Yang, et al. "ADAM22 Enhances Lymphatic Metastasis and Epithelial-mesenchymal Transition in Head and Neck Squamous Cell Carcinoma Cells Through Integrin Signaling." Medical Oncology (Northwood, London, England) 42, no. 7 (2025): 236. https://doi.org/10.1007/s12032-025-02789-z.

MLA (9th ed.) Citation

K, Yang, et al. "ADAM22 Enhances Lymphatic Metastasis and Epithelial-mesenchymal Transition in Head and Neck Squamous Cell Carcinoma Cells Through Integrin Signaling." Medical Oncology (Northwood, London, England), vol. 42, no. 7, 2025, p. 236, https://doi.org/10.1007/s12032-025-02789-z.